close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

UFP Technologies, Inc. - Common Stock (NQ:UFPT)

303.47 +3.65 (+1.22%)
Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about UFP Technologies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
UFP Technologies: 3 Key Takeaways for Long-Term Investors ↗
The Dominican Republic production shift at AJR is still waiting on customer qualification, so its cost-benefit has not yet reached the margins. 
Via The Motley Fool
Topics Earnings
News headline image
What UFP Technologies (UFPT) Said on Its Q3 Earnings Call ↗
UFP Technologies (NASDAQ:UFPT) reported third-quarter 2026 sales growth of 11.6%, supported by broad demand across its medical technology portfolio, while management outlined continued investments in... 
Via MarketBeat
Topics Earnings
News headline image
GoodRx, Evolent Health, UFP Technologies, Centene, and HCA Healthcare shares skyrocket, what you need to know
What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat... 
Via StockStory
News headline image
UFP Technologies (UFPT) Q3 2026 Earnings Call Transcript ↗
Margin gains and a shifting robotic surgery outlook shape the quarter. 
Via The Motley Fool
Topics Earnings
UFP Technologies (NASDAQ:UFPT) Posts Inline Q3 Revenue and Clear EPS Beat Amid Cautious Trading ↗
Via Chartmill
News headline image
UFPT Q3 2026 deep dive: broad-based MedTech growth and acquisition strategy drive results
Medical products company UFP Technologies (NASDAQ:UFPT) beat Wall Street’s revenue expectations in Q3 2026, with sales up 11.6% year on year to $172.4 millio... 
Via StockStory
News headline image
UFP Technologies (NASDAQ:UFPT) delivers impressive Q3 2026
Medical products company UFP Technologies (NASDAQ:UFPT) reported revenue ahead of Wall Street’s expectations in Q3 2026, with revenue rising 11.6% year on ye... 
Via StockStory
News headline image
UFP Technologies (UFPT) Q3 earnings report preview: what to look for
Medical products company UFP Technologies (NASDAQ:UFPT) will be announcing earnings results this Tuesday after market close. Here’s what to expect. UFP Techn... 
Via StockStory
Topics Artificial Intelligence
News headline image
2 Reasons to avoid UFPT and 1 stock to buy instead
The past six months have been a windfall for UFP Technologies’s shareholders. The company’s stock price has jumped 41.9%, hitting $289.13 per share. This was... 
Via StockStory
Topics Supply Chain
News headline image
Q2 Earnings Roundup: UFP Technologies (NASDAQ:UFPT) And The Rest Of The Drug Development Inputs & Services Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how drug development input... 
Via StockStory
News headline image
3 Russell 2000 Stocks That Concern Us
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
News headline image
1 Cash-Producing Stock for Long-Term Investors and 2 We Find Risky
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc... 
Via StockStory
News headline image
Q2 Earnings Review: Drug Development Inputs & Services Stocks Led by Azenta (NASDAQ:AZTA)
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Azenta... 
Via StockStory
News headline image
UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares ↗
Feldmann reduced her direct stake by 18%. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds ↗
UFP Technologies (NASDAQ:UFPT) outlined its strategy to expand through organic growth and acquisitions, emphasizing its role as a contract development and manufacturing organization serving... 
Via MarketBeat
Topics Supply Chain
News headline image
2 Profitable Stocks with Exciting Potential and 1 Facing Headwinds
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
UFP Technologies (UFPT) Q2 2026 Earnings Call Transcript ↗
Record $2.92 adjusted EPS and 15.1% net sales growth highlight strong MedTech momentum. 
Via The Motley Fool
Topics Earnings
News headline image
The Top 5 Analyst Questions From UFP Technologies’s Q2 Earnings Call
UFP Technologies delivered a calendar second quarter marked by strong, broad-based growth across its MedTech platform, which exceeded Wall Street’s revenue a... 
Via StockStory
Topics Earnings
News headline image
Why UFP Technologies Stock Is Skyrocketing Today ↗
UFP Technologies easily surpassed Wall Street's expectations and continued to deliver double-digit sales growth. 
Via The Motley Fool
News headline image
UFP Technologies Q2 Earnings Call Highlights ↗
UFP Technologies (NASDAQ:UFPT) reported second-quarter 2026 sales growth of 15.1% to $174 million, supported by broad-based demand across its medical technology portfolio, while adjusted earnings per... 
Via MarketBeat
Topics Earnings
News headline image
Why Is UFP Technologies (UFPT) Stock Soaring Today
What Happened? Shares of medical products company UFP Technologies (NASDAQ:UFPT) jumped 18.5% in the morning session after the company reported impressive se... 
Via StockStory
News headline image
UFP Technologies Reports Q2 2026 Results: Full Earnings Call Transcript ↗
UFP Technologies (NASDAQ:UFPT) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For... 
Via Benzinga
Topics Earnings
News headline image
UFP Technologies’s (NASDAQ:UFPT) Q2 CY2026: Strong Sales, Stock Soars
Medical products company UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 15.1% year on y... 
Via StockStory
News headline image
Earnings To Watch: UFP Technologies (UFPT) Reports Q2 Results Tomorrow
Medical products company UFP Technologies (NASDAQ:UFPT) will be reporting results this Monday after market hours. Here’s what you need to know. UFP Technolog... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks with Warning Signs
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying ↗
As small caps outpace the S&P 500 in 2026's rotation, UFP Technologies, Willdan Group, and NWPX Infrastructure show earnings and growth catalysts worth watching this year. 
Via MarketBeat
Topics Earnings Stocks
News headline image
2 Reasons UFPT is Risky and 1 Stock to Buy Instead
Over the past six months, UFP Technologies’s shares (currently trading at $244.72) have posted a disappointing 8.2% loss, well below the S&P 500’s 7.7% gain.... 
Via StockStory
Topics Stocks Supply Chain
News headline image
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
3 Hyped Up Stocks with Questionable Fundamentals
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements... 
Via StockStory
News headline image
UFP Technologies Director Sells $287,000 After Option Exercise as Shares Stay Flat ↗
This medical device supplier, known for custom healthcare components, reported a notable insider sale amid ongoing sector diversification. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.